propranolol has been researched along with peoniflorin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, K; Ohta, H; Shimizu, M; Watanabe, H | 1 |
| Lu, C; Xiao, Z; Yu, J; Zhang, Y; Zhao, R | 1 |
2 other study(ies) available for propranolol and peoniflorin
| Article | Year |
|---|---|
Involvement of beta-adrenergic systems in the antagonizing effect of paeoniflorin on the scopolamine-induced deficit in radial maze performance in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atenolol; Benzoates; Bridged-Ring Compounds; Glucosides; Male; Memory; Monoterpenes; Propranolol; Psychomotor Performance; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Scopolamine | 1993 |
Paeoniflorin suppressed IL-22 via p38 MAPK pathway and exerts anti-psoriatic effect.
Topics: Animals; Blotting, Western; Cell Line; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glucosides; Guinea Pigs; Humans; Interleukin-22; Interleukins; Lipopolysaccharides; Male; Monoterpenes; p38 Mitogen-Activated Protein Kinases; Paeonia; Phosphorylation; Propranolol; Psoriasis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2017 |